A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Doxorubicin Impurity 13 - Request Quote

Picture of Doxorubicin Impurity 13

Doxorubicin Impurity 13

SZ CAT No:SZ-D051009
CAS No
NA
Mol.F.
C27H29NO12
Mol.Wt.
559.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Doxorubicin Impurity 13 is chemically (8R,10S)-10-((4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,7,8,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione. Doxorubicin Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Doxorubicin Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Doxorubicin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Doxorubicin Impurity 13

Purchase Doxorubicin Impurity 13

Doxorubicin Impurity 13 suppliers

Doxorubicin Impurity 13 manufacturers

Doxorubicin Impurity 13 price

Order Doxorubicin Impurity 13

Enquire Doxorubicin Impurity 13

Doxorubicin Impurity 13 cost

Doxorubicin Impurity 13 Supplier

Doxorubicin Impurity 13 Distributor

Doxorubicin Impurity 13 for Method Validation

Doxorubicin Reference Standard

Doxorubicin Impurity 13 for ANDA Filing

Doxorubicin Impurity 13 for Forced Degradation Studies

Doxorubicin Impurity 13 Identification Standards

Doxorubicin Impurity 13 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,